XBiotech Inc. — Director's Dealing 2019

Mar 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2019-02-07

Reporting Person: SHIVASWAMY SUSHMA (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-07	Common Stock	M	4500	$2.50	Acquired	4500	Direct
2019-02-07	Common Stock	S	4500	$10.00	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-07	Stock options	$2.50	M	4500	Disposed	2019-05-26	Common Stocks (4500)	Direct